Literature DB >> 25304811

Screening aberrant methylation profile in esophageal squamous cell carcinoma for Kazakhs in Xinjiang area of China.

Yan Chen1, Dong Yin, Lei Li, Yan-Chao Deng, Wei Tian.   

Abstract

To screen the aberrant methylation genes in esophageal squamous cell carcinoma (ESCC) for Kazakh nationality in Xinjiang, and the aberrant DNA methylation genes pattern provides a clue for deeply study on ESCC mechanism. Illumina Human Methylation 450 K chip was used to screen the genome-wide methylation on six cancer tissues and six adjacent normal tissues of ESCC in Kazakh people. Meanwhile, mRNA library was constructed by scanning the RNA expression on two cancer tissues and two adjacent normal tissues by Hiseq2000. After association study between the methylation profile and expression profile, aberrant DNA methylated genes were screened out and were uploaded to the GoMiner and the KEGG, completing the bioinformatic analysis. There were 227 hypermethylation genes and 6 hypomethylated genes in cancer tissue, mRNA expression varied from 0.0312 to 8,192 in cancer tissues compared with 0.0312-1,024 in adjacent normal tissues. The correlation study indicated that there were 10 loci in 10 down-regulated genes of hypermethylated in negative correlation group. Additionally, there were 11 loci in 10 up-regulated genes in negative group. Using GoMiner to do GO analysis on aberrant DNA methylation genes, RAPGEFL1, TP53AIP1, KIAA1522, DUOXA2 were identified not involved in any biological processes. ALDH1L1 participated in folinic acid catabolism and CAPN1 positively regulated the cell proliferation. And ALDH1L1 involved in one carbon metabolism and CAPN1 participate in the apoptosis process by applying pathway analysis. The aberrant DNA methylation profiles were established and provided a clue for deeply study on ESCC of Kazakh nationality.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25304811     DOI: 10.1007/s11033-014-3788-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  9 in total

1.  Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma.

Authors:  Eun Ju Lee; Bo Bin Lee; Jin Wook Kim; Young Mog Shim; I Hoseok; Joungho Han; Eun Yoon Cho; Joobae Park; Duk-Hwan Kim
Journal:  Eur J Cancer       Date:  2006-03-27       Impact factor: 9.162

2.  Alcohol intake and folate antagonism via CYP2E1 and ALDH1: effects on oral carcinogenesis.

Authors:  Phillip H Hwang; Lisa Lian; Athanasios I Zavras
Journal:  Med Hypotheses       Date:  2011-11-17       Impact factor: 1.538

3.  Tumour class prediction and discovery by microarray-based DNA methylation analysis.

Authors:  Péter Adorján; Jürgen Distler; Evelyne Lipscher; Fabian Model; Jürgen Müller; Cécile Pelet; Aron Braun; Andrea R Florl; David Gütig; Gabi Grabs; André Howe; Mischo Kursar; Ralf Lesche; Erik Leu; André Lewin; Sabine Maier; Volker Müller; Thomas Otto; Christian Scholz; Wolfgang A Schulz; Hans-Helge Seifert; Ina Schwope; Heike Ziebarth; Kurt Berlin; Christian Piepenbrock; Alexander Olek
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

4.  Identification of novel target genes by an epigenetic reactivation screen of renal cancer.

Authors:  Inmaculada Ibanez de Caceres; Essel Dulaimi; Amanda M Hoffman; Tahseen Al-Saleem; Robert G Uzzo; Paul Cairns
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

5.  Epigenetic Silencing of ALDH1L1, a Metabolic Regulator of Cellular Proliferation, in Cancers.

Authors:  Natalia V Oleinik; Natalia I Krupenko; Sergey A Krupenko
Journal:  Genes Cancer       Date:  2011-02

6.  Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in ovarian cancer.

Authors:  D Salehin; I Fromberg; C Haugk; B Dohmen; T Georg; R M Bohle; D Bauerschlag; M Thill; M Friedrich
Journal:  Eur J Gynaecol Oncol       Date:  2011       Impact factor: 0.196

7.  [Hypermethylation of promoter region of RAS association domain family gene1A in esophageal squamous cell carcinoma and significance thereof].

Authors:  De-gang Cong; Sheng-fa Wang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2007-11-06

8.  DNA methylation in esophageal diseases including cancer: special reference to hMLH1 gene promoter status.

Authors:  Mohan Vasavi; Shivani Ponnala; Kusumanjali Gujjari; Prabhakar Boddu; Ravi Shankar Bharatula; Rupender Prasad; Yog Raj Ahuja; Qurratulain Hasan
Journal:  Tumori       Date:  2006 Mar-Apr

9.  Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation.

Authors:  Luke O Dannenberg; Howard J Edenberg
Journal:  BMC Genomics       Date:  2006-07-19       Impact factor: 3.969

  9 in total
  7 in total

Review 1.  Epimutation in inherited metabolic disorders: the influence of aberrant transcription in adjacent genes.

Authors:  Jean-Louis Guéant; Youssef Siblini; Céline Chéry; Guillaume Schmitt; Rosa-Maria Guéant-Rodriguez; David Coelho; David Watkins; David S Rosenblatt; Abderrahim Oussalah
Journal:  Hum Genet       Date:  2022-02-21       Impact factor: 5.881

2.  ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma.

Authors:  Guangzhi Zhu; Xiwen Liao; Chuangye Han; Xiaoguang Liu; Long Yu; Wei Qin; Sicong Lu; Hao Su; Zhiwei Chen; Zhengtao Liu; Yu Liang; Jianlu Huang; Tingdong Yu; Chengkun Yang; Ketuan Huang; Liming Shang; Xinping Ye; Lequn Li; Xue Qin; Kaiyin Xiao; Minhao Peng; Tao Peng
Journal:  Oncol Rep       Date:  2017-07-14       Impact factor: 3.906

3.  KIAA1522 overexpression promotes tumorigenicity and metastasis of esophageal cancer cells through potentiating the ERK activity.

Authors:  Zhi-Hui Xie; Jing Yu; Li Shang; Yi-Qing Zhu; Jia-Jie Hao; Yan Cai; Xin Xu; Yu Zhang; Ming-Rong Wang
Journal:  Onco Targets Ther       Date:  2017-07-26       Impact factor: 4.147

4.  Mutations, Differential Gene Expression, and Chimeric Transcripts in Esophageal Squamous Cell Carcinoma Show High Heterogeneity.

Authors:  Paulo Thiago de Souza-Santos; Sheila Coelho Soares Lima; Pedro Nicolau-Neto; Mariana Boroni; Nathalia Meireles Da Costa; Lilian Brewer; Albert Nobre Menezes; Carolina Furtado; Miguel Angelo Martins Moreira; Hector N Seuanez; Tatiana de Almeida Simão; Luis Felipe Ribeiro Pinto
Journal:  Transl Oncol       Date:  2018-08-29       Impact factor: 4.243

5.  KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer.

Authors:  Yi-Zhen Liu; Hai Yang; Jian Cao; Yan-Yi Jiang; Jia-Jie Hao; Xin Xu; Yan Cai; Ming-Rong Wang
Journal:  Sci Rep       Date:  2016-04-21       Impact factor: 4.379

6.  Deep Sequencing Revealed a CpG Methylation Pattern Associated With ALDH1L1 Suppression in Breast Cancer.

Authors:  Artemy D Beniaminov; Grigory A Puzanov; George S Krasnov; Dmitry N Kaluzhny; Tatiana P Kazubskaya; Eleonora A Braga; Anna V Kudryavtseva; Nataliya V Melnikova; Alexey A Dmitriev
Journal:  Front Genet       Date:  2018-05-15       Impact factor: 4.599

7.  HIPK3 Promotes Growth and Metastasis of Esophageal Squamous Cell Carcinoma via Regulation of miR-599/c-MYC Axis.

Authors:  Yufeng Ba; Yining Liu; Changsheng Li; Yu Zhu; Wenqun Xing
Journal:  Onco Targets Ther       Date:  2020-03-06       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.